Literature DB >> 106001

Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.

L Gray, A Kreger.   

Abstract

The intratracheal administration of highly purified Pseudomonas aeruginosa proteases (ca. 10 to 100 microgram) elicited extensive, grossly observable rabbit lung damage by 3 h postinjection. Light and electron microscopic characterization of the lesions revealed: (i) progressive injury and necrosis of type I epithelial cells and capillary endothelial cells from 3 h to 1 day postinjection, and progressively increasing accumulations of erythrocytes, plasma proteins, fibrin, and released type II epithelial cell lamellar bodies in alveolar lumina during that time period; (ii) progressively increasing accumulations of macrophages, but not of polymorphonuclear leukocytes, in alveolar lumina from 3 h to 6 days postinjection; (iii) progressive hyperplasia of type II epithelial cells from 12 h to 4 days postinjection; (iv) progressive infiltration of alveolar septa by mononuclear inflammatory cells (interstitial pneumonitis) from 2 to 6 days postinjection; (v) no loss of alveolar septal connective tissue and no damage to pulmonary arterioles and venules; and (vi) almost normal alveolar structure by ca. 8 days postinjection. The study revealed that the intra-alveolar hemorrhage, the injury and necrosis of alveolar septal cells, and the infiltration by mononuclear cells that have been reported to occur during human pseudomonas pneumonia can also be elicited by the experimental administration of pseudomonas proteases. Thus, the results support the idea that in vivo production and activity of P. aeruginosa proteases is important, at least in part, in eliciting the lung damage characteristic of pseudomonas pneumonia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106001      PMCID: PMC550702          DOI: 10.1128/iai.23.1.150-159.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The induction of emphysema with elastase. II. Changes in connective tissue.

Authors:  C Kuhn; S Y Yu; M Chraplyvy; H E Linder; R M Senior
Journal:  Lab Invest       Date:  1976-04       Impact factor: 5.662

2.  Passive hemagglutination reaction test using formalinized sheep erythrocytes treated with tannic acid and coated with proteast or elastase of Pseudomonas aeruginosa.

Authors:  J Y Homma; T Tomiyama; H Sano; Y Hirao; K Saku
Journal:  Jpn J Exp Med       Date:  1975-10

3.  Cytotoxic effects of leukocidin from Pseudomonas aeruginosa on polymorphonuclear leukocytes from cattle.

Authors:  W Scharmann
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors:  J D Klinger; D C Straus; C B Hilton; J A Bass
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

5.  Production of protease and elastase by Pseudomonas aeruginosa strains isolated from patients.

Authors:  K Morihara; H Tsuzuki
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

6.  Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.

Authors:  J Y Homma; C Abe; K Tanamoto; Y Hirao; K Morihara; H Tsuzuki; R Yanagawa; E Honda; Y Aoi; Y Fujimoto; M Goryo; N Imazeki; H Noda; A Goda; S Takeuchi; T Ishihara
Journal:  Jpn J Exp Med       Date:  1978-04

7.  In vivo studies on protease and elastase from Pseudomonas aeruginosa.

Authors:  K Kawaharajo; J Y Homma; Y Aoyama; K Morihara
Journal:  Jpn J Exp Med       Date:  1975-04

8.  Experimental studies on the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence for toxin production during Pseudomonas infection of burned skin tissues.

Authors:  C B Saelinger; K Snell; I A Holder
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

9.  In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.

Authors:  M Lynn; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

10.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  26 in total

1.  Inhibition of Aspergillus fumigatus elastase with monoclonal antibodies produced by using denatured elastase as an immunogen.

Authors:  M Frosco; C Fahed; T Chase; J D Macmillan
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

3.  Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.

Authors:  L W Heck; K Morihara; D R Abrahamson
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 4.  Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease.

Authors:  D J Harrington
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; K Morihara; W B McRae; E J Miller
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Nutritional factors controlling exocellular protease production by Pseudomonas aeruginosa.

Authors:  S E Jensen; I T Fecycz; J N Campbell
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

8.  Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A.

Authors:  L D Hazlett; R S Berk; B H Iglewski
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Authors:  G Döring; N Høiby
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.

Authors:  T G Theander; A Kharazmi; B K Pedersen; L D Christensen; N Tvede; L K Poulsen; N Odum; M Svenson; K Bendtzen
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.